PATENT CLAIM ANALYSIS

Application Number: 15954059
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are compositions and methods for the modulation of miR-214 for the treatment and/or prevention of fibrosis and fibroproliferative conditions.

Claim (Index 29):
The method of  claim 28 , wherein the cancer is selected from liver cancer, breast cancer, lung cancer, colon cancer, ovarian cancer, cervical cancer, brain cancer, esophageal cancer, kidney cancer, melanoma, oral cancer, pancreatic cancer, prostate cancer, rectal cancer, stomach cancer, bladder cancer, thyroid cancer, and testicular cancer.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 91.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14872564', '15380629', '13811423', '14334872', '12919592']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.836705111066557
- 35 USC 102 Novelty (BERT): 0.5481550011950943
- Combined Prediction Score: 0.8078501000794107
- Mean Citation Score: 430.131018
- Max Citation Score: 450.4595
- Similarity Product: 260.21897007912395

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test